Summary:
This is an 18 month study for subjects with mild/early alzheimer's disease.
Qualified Participants Must:
Be between 50 and 90 years of age
Have a reliable partner/caregiver who spends at least 10 hours per week with subject
Not need diagnosis of alzheimer's to screen for study
Can be taking medications, aricept, exelon or namenda
Qualified Participants May Receive:
If you qualify and sign an informed consent form for a study, you may receive reimbursement for travel and inconvenience for every visit you complete.